English

IGM Biosciences, Inc.

EDGAR

IGMS Quarterly report (10-Q) · filed 2025-07-31

31 filing records in this dataset, filed from 2019-08-19 to 2025-07-31. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 30.6 million USD 2025-06-30 Source
Exact value

30649000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 25.9 million shares 2021-09-30 Source
Exact value

25905471 shares

Reported share-count change

6.78% · 1.64 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

24261412 shares · 2020-09-30· Source
25905471 shares · 2021-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-53.4 million USD

2024-07-01 – 2025-06-30

Exact inputs and evidence

Net income: -61430000 USD · 2024-07-01 – 2024-09-30 Source
Net income: -195795000 USD · 2024-01-01 – 2024-12-31 Source
Net income: -159148000 USD · 2024-01-01 – 2024-09-30 Source
Net income: -52892000 USD · 2025-01-01 – 2025-03-31 Source
Net income: 97584000 USD · 2025-04-01 – 2025-06-30 Source

Operating cash flow

-157 million USD

2024-07-01 – 2025-06-30

Exact inputs and evidence

Operating cash flow: -118176000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -79791000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -152996000 USD · 2024-01-01 – 2024-12-31 Source
Operating cash flow: -118176000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -32519000 USD · 2025-01-01 – 2025-03-31 Source
Operating cash flow: -83308000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -32519000 USD · 2025-01-01 – 2025-03-31 Source

Capital expenditure

2.19 million USD

2024-07-01 – 2025-06-30

Exact inputs and evidence

Capital expenditure: 4990000 USD · 2024-01-01 – 2024-09-30 Source
Capital expenditure: 3698000 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 5852000 USD · 2024-01-01 – 2024-12-31 Source
Capital expenditure: 4990000 USD · 2024-01-01 – 2024-09-30 Source
Capital expenditure: 31000 USD · 2025-01-01 – 2025-03-31 Source
Capital expenditure: 32000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 31000 USD · 2025-01-01 – 2025-03-31 Source

Free cash flow

-159 million USD

2024-07-01 – 2025-06-30

Exact inputs and evidence

Operating cash flow: -118176000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -79791000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -152996000 USD · 2024-01-01 – 2024-12-31 Source
Operating cash flow: -118176000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -32519000 USD · 2025-01-01 – 2025-03-31 Source
Operating cash flow: -83308000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -32519000 USD · 2025-01-01 – 2025-03-31 Source
Capital expenditure: 4990000 USD · 2024-01-01 – 2024-09-30 Source
Capital expenditure: 3698000 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 5852000 USD · 2024-01-01 – 2024-12-31 Source
Capital expenditure: 4990000 USD · 2024-01-01 – 2024-09-30 Source
Capital expenditure: 31000 USD · 2025-01-01 – 2025-03-31 Source
Capital expenditure: 32000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 31000 USD · 2025-01-01 – 2025-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-07-31.

Financial data available through: 2024-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 8 of 11 periods available· newest 2024-12-31
Net income: 8 of 11 periods available· newest 2024-12-31
Operating cash flow: 8 of 11 periods available· newest 2024-12-31
Capital expenditure: 8 of 11 periods available· newest 2024-12-31
Total assets: 7 of 11 periods available· newest 2024-12-31
Total liabilities: 7 of 11 periods available· newest 2024-12-31
Current assets: 7 of 11 periods available· newest 2024-12-31
Current liabilities: 7 of 11 periods available· newest 2024-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2024-12-31
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2020-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 50.62 million

Prior period

−USD 246.42 million

2023-01-01 – 2023-12-31
Current period

−USD 195.8 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-195795000 − -246416000 = 50621000 USD

-246416000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-195795000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · IGM Biosciences, Inc. · 2024-12-31 IGM Biosciences, Inc. (edgar:1496323) Year-over-year change in Net income: 50621000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -195795000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#3393360 Filing: 000095017025034597 Input fundies:NetIncome: -246416000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#3395098 Filing: 000095017025034597
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 39.24 million

Prior period

−USD 192.23 million

2023-01-01 – 2023-12-31
Current period

−USD 153 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-152996000 − -192231000 = 39235000 USD

-192231000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-152996000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · IGM Biosciences, Inc. · 2024-12-31 IGM Biosciences, Inc. (edgar:1496323) Year-over-year change in Operating cash flow: 39235000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -152996000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1958917 Filing: 000095017025034597 Input fundies:OperatingCashFlow: -192231000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1960678 Filing: 000095017025034597
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-52.7%

Prior period

USD 12.38 million

2023-01-01 – 2023-12-31
Current period

USD 5.85 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

5852000 − 12381000 = -6529000 USD

12381000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
5852000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · IGM Biosciences, Inc. · 2024-12-31 IGM Biosciences, Inc. (edgar:1496323) Year-over-year change in Capital expenditure: -6529000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 5852000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1971128 Filing: 000095017025034597 Input fundies:CapitalExpenditure: 12381000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1972774 Filing: 000095017025034597
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2017-01-01 – 2017-12-31	−USD 11.05 million Exact value Exact value: -11054000 USD 2017-01-01 – 2017-12-31: -11054000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IGM Biosciences, Inc. · 2017-12-31 IGM Biosciences, Inc. (edgar:1496323) Net Income: -11054000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11054000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000156459020013183/igms-20191231.xml#127442 Filing: 000156459020013183 The citation records this snapshot. The page link may show a newer release later.	−USD 10.36 million Exact value Exact value: -10357000 USD 2017-01-01 – 2017-12-31: -10357000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IGM Biosciences, Inc. · 2017-12-31 IGM Biosciences, Inc. (edgar:1496323) Operating Cash Flow: -10357000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10357000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000156459020013183/igms-20191231.xml#161027 Filing: 000156459020013183 The citation records this snapshot. The page link may show a newer release later.	USD 385,000 Exact value Exact value: 385000 USD 2017-01-01 – 2017-12-31: 385000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IGM Biosciences, Inc. · 2017-12-31 IGM Biosciences, Inc. (edgar:1496323) Capital Expenditure: 385000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 385000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000156459020013183/igms-20191231.xml#161658 Filing: 000156459020013183 The citation records this snapshot. The page link may show a newer release later.	−USD 10.74 million Calculation and evidence -10357000 − 385000 USD Exact free cash flow: -10742000 USD 2017-01-01 – 2017-12-31: -10357000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 385000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IGM Biosciences, Inc. · 2017-12-31 IGM Biosciences, Inc. (edgar:1496323) Free cash flow: -10742000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10357000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000156459020013183/igms-20191231.xml#161027 Filing: 000156459020013183 Input fundies:CapitalExpenditure: 385000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000156459020013183/igms-20191231.xml#161658 Filing: 000156459020013183 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 22.71 million Exact value Exact value: -22711000 USD 2018-01-01 – 2018-12-31: -22711000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IGM Biosciences, Inc. · 2018-12-31 IGM Biosciences, Inc. (edgar:1496323) Net Income: -22711000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22711000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000156459021016675/igms-20201231.xml#146571 Filing: 000156459021016675 The citation records this snapshot. The page link may show a newer release later.	−USD 20.04 million Exact value Exact value: -20044000 USD 2018-01-01 – 2018-12-31: -20044000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IGM Biosciences, Inc. · 2018-12-31 IGM Biosciences, Inc. (edgar:1496323) Operating Cash Flow: -20044000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20044000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000156459021016675/igms-20201231.xml#182178 Filing: 000156459021016675 The citation records this snapshot. The page link may show a newer release later.	USD 788,000 Exact value Exact value: 788000 USD 2018-01-01 – 2018-12-31: 788000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IGM Biosciences, Inc. · 2018-12-31 IGM Biosciences, Inc. (edgar:1496323) Capital Expenditure: 788000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 788000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000156459021016675/igms-20201231.xml#182811 Filing: 000156459021016675 The citation records this snapshot. The page link may show a newer release later.	−USD 20.83 million Calculation and evidence -20044000 − 788000 USD Exact free cash flow: -20832000 USD 2018-01-01 – 2018-12-31: -20044000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 788000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IGM Biosciences, Inc. · 2018-12-31 IGM Biosciences, Inc. (edgar:1496323) Free cash flow: -20832000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20044000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000156459021016675/igms-20201231.xml#182178 Filing: 000156459021016675 Input fundies:CapitalExpenditure: 788000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000156459021016675/igms-20201231.xml#182811 Filing: 000156459021016675 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 43.13 million Exact value Exact value: -43133000 USD 2019-01-01 – 2019-12-31: -43133000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IGM Biosciences, Inc. · 2019-12-31 IGM Biosciences, Inc. (edgar:1496323) Net Income: -43133000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -43133000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017022004842/igms-20211231.htm#3578909 Filing: 000095017022004842 The citation records this snapshot. The page link may show a newer release later.	−USD 45.12 million Exact value Exact value: -45116000 USD 2019-01-01 – 2019-12-31: -45116000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IGM Biosciences, Inc. · 2019-12-31 IGM Biosciences, Inc. (edgar:1496323) Operating Cash Flow: -45116000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -45116000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017022004842/igms-20211231.htm#2406876 Filing: 000095017022004842 The citation records this snapshot. The page link may show a newer release later.	USD 2.34 million Exact value Exact value: 2337000 USD 2019-01-01 – 2019-12-31: 2337000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IGM Biosciences, Inc. · 2019-12-31 IGM Biosciences, Inc. (edgar:1496323) Capital Expenditure: 2337000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2337000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017022004842/igms-20211231.htm#2420749 Filing: 000095017022004842 The citation records this snapshot. The page link may show a newer release later.	−USD 47.45 million Calculation and evidence -45116000 − 2337000 USD Exact free cash flow: -47453000 USD 2019-01-01 – 2019-12-31: -45116000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 2337000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IGM Biosciences, Inc. · 2019-12-31 IGM Biosciences, Inc. (edgar:1496323) Free cash flow: -47453000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -45116000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017022004842/igms-20211231.htm#2406876 Filing: 000095017022004842 Input fundies:CapitalExpenditure: 2337000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017022004842/igms-20211231.htm#2420749 Filing: 000095017022004842 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 81.36 million Exact value Exact value: -81355000 USD 2020-01-01 – 2020-12-31: -81355000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IGM Biosciences, Inc. · 2020-12-31 IGM Biosciences, Inc. (edgar:1496323) Net Income: -81355000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -81355000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017023010920/igms-20221231.htm#1990949 Filing: 000095017023010920 The citation records this snapshot. The page link may show a newer release later.	−USD 67.88 million Exact value Exact value: -67881000 USD 2020-01-01 – 2020-12-31: -67881000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IGM Biosciences, Inc. · 2020-12-31 IGM Biosciences, Inc. (edgar:1496323) Operating Cash Flow: -67881000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -67881000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017023010920/igms-20221231.htm#2374763 Filing: 000095017023010920 The citation records this snapshot. The page link may show a newer release later.	USD 17.5 million Exact value Exact value: 17502000 USD 2020-01-01 – 2020-12-31: 17502000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IGM Biosciences, Inc. · 2020-12-31 IGM Biosciences, Inc. (edgar:1496323) Capital Expenditure: 17502000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 17502000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017023010920/igms-20221231.htm#2390264 Filing: 000095017023010920 The citation records this snapshot. The page link may show a newer release later.	−USD 85.38 million Calculation and evidence -67881000 − 17502000 USD Exact free cash flow: -85383000 USD 2020-01-01 – 2020-12-31: -67881000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 17502000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IGM Biosciences, Inc. · 2020-12-31 IGM Biosciences, Inc. (edgar:1496323) Free cash flow: -85383000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -67881000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017023010920/igms-20221231.htm#2374763 Filing: 000095017023010920 Input fundies:CapitalExpenditure: 17502000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017023010920/igms-20221231.htm#2390264 Filing: 000095017023010920 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 165.16 million Exact value Exact value: -165164000 USD 2021-01-01 – 2021-12-31: -165164000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IGM Biosciences, Inc. · 2021-12-31 IGM Biosciences, Inc. (edgar:1496323) Net Income: -165164000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -165164000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017024027924/igms-20231231.htm#1503271 Filing: 000095017024027924 The citation records this snapshot. The page link may show a newer release later.	−USD 124.98 million Exact value Exact value: -124982000 USD 2021-01-01 – 2021-12-31: -124982000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IGM Biosciences, Inc. · 2021-12-31 IGM Biosciences, Inc. (edgar:1496323) Operating Cash Flow: -124982000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -124982000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017024027924/igms-20231231.htm#1747946 Filing: 000095017024027924 The citation records this snapshot. The page link may show a newer release later.	USD 13.24 million Exact value Exact value: 13244000 USD 2021-01-01 – 2021-12-31: 13244000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IGM Biosciences, Inc. · 2021-12-31 IGM Biosciences, Inc. (edgar:1496323) Capital Expenditure: 13244000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13244000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017024027924/igms-20231231.htm#1757336 Filing: 000095017024027924 The citation records this snapshot. The page link may show a newer release later.	−USD 138.23 million Calculation and evidence -124982000 − 13244000 USD Exact free cash flow: -138226000 USD 2021-01-01 – 2021-12-31: -124982000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 13244000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IGM Biosciences, Inc. · 2021-12-31 IGM Biosciences, Inc. (edgar:1496323) Free cash flow: -138226000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -124982000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017024027924/igms-20231231.htm#1747946 Filing: 000095017024027924 Input fundies:CapitalExpenditure: 13244000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017024027924/igms-20231231.htm#1757336 Filing: 000095017024027924 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 221.1 million Exact value Exact value: -221102000 USD 2022-01-01 – 2022-12-31: -221102000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IGM Biosciences, Inc. · 2022-12-31 IGM Biosciences, Inc. (edgar:1496323) Net Income: -221102000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -221102000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1882529 Filing: 000095017025034597 The citation records this snapshot. The page link may show a newer release later.	−USD 5.85 million Exact value Exact value: -5853000 USD 2022-01-01 – 2022-12-31: -5853000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IGM Biosciences, Inc. · 2022-12-31 IGM Biosciences, Inc. (edgar:1496323) Operating Cash Flow: -5853000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5853000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1962439 Filing: 000095017025034597 The citation records this snapshot. The page link may show a newer release later.	USD 10.21 million Exact value Exact value: 10206000 USD 2022-01-01 – 2022-12-31: 10206000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IGM Biosciences, Inc. · 2022-12-31 IGM Biosciences, Inc. (edgar:1496323) Capital Expenditure: 10206000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10206000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1974421 Filing: 000095017025034597 The citation records this snapshot. The page link may show a newer release later.	−USD 16.06 million Calculation and evidence -5853000 − 10206000 USD Exact free cash flow: -16059000 USD 2022-01-01 – 2022-12-31: -5853000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 10206000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IGM Biosciences, Inc. · 2022-12-31 IGM Biosciences, Inc. (edgar:1496323) Free cash flow: -16059000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5853000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1962439 Filing: 000095017025034597 Input fundies:CapitalExpenditure: 10206000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1974421 Filing: 000095017025034597 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 246.42 million Exact value Exact value: -246416000 USD 2023-01-01 – 2023-12-31: -246416000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IGM Biosciences, Inc. · 2023-12-31 IGM Biosciences, Inc. (edgar:1496323) Net Income: -246416000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -246416000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#3395098 Filing: 000095017025034597 The citation records this snapshot. The page link may show a newer release later.	−USD 192.23 million Exact value Exact value: -192231000 USD 2023-01-01 – 2023-12-31: -192231000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IGM Biosciences, Inc. · 2023-12-31 IGM Biosciences, Inc. (edgar:1496323) Operating Cash Flow: -192231000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -192231000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1960678 Filing: 000095017025034597 The citation records this snapshot. The page link may show a newer release later.	USD 12.38 million Exact value Exact value: 12381000 USD 2023-01-01 – 2023-12-31: 12381000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IGM Biosciences, Inc. · 2023-12-31 IGM Biosciences, Inc. (edgar:1496323) Capital Expenditure: 12381000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12381000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1972774 Filing: 000095017025034597 The citation records this snapshot. The page link may show a newer release later.	−USD 204.61 million Calculation and evidence -192231000 − 12381000 USD Exact free cash flow: -204612000 USD 2023-01-01 – 2023-12-31: -192231000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 12381000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IGM Biosciences, Inc. · 2023-12-31 IGM Biosciences, Inc. (edgar:1496323) Free cash flow: -204612000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -192231000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1960678 Filing: 000095017025034597 Input fundies:CapitalExpenditure: 12381000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1972774 Filing: 000095017025034597 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 195.8 million Exact value Exact value: -195795000 USD 2024-01-01 – 2024-12-31: -195795000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IGM Biosciences, Inc. · 2024-12-31 IGM Biosciences, Inc. (edgar:1496323) Net Income: -195795000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -195795000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#3393360 Filing: 000095017025034597 The citation records this snapshot. The page link may show a newer release later.	−USD 153 million Exact value Exact value: -152996000 USD 2024-01-01 – 2024-12-31: -152996000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IGM Biosciences, Inc. · 2024-12-31 IGM Biosciences, Inc. (edgar:1496323) Operating Cash Flow: -152996000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -152996000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1958917 Filing: 000095017025034597 The citation records this snapshot. The page link may show a newer release later.	USD 5.85 million Exact value Exact value: 5852000 USD 2024-01-01 – 2024-12-31: 5852000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IGM Biosciences, Inc. · 2024-12-31 IGM Biosciences, Inc. (edgar:1496323) Capital Expenditure: 5852000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5852000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1971128 Filing: 000095017025034597 The citation records this snapshot. The page link may show a newer release later.	−USD 158.85 million Calculation and evidence -152996000 − 5852000 USD Exact free cash flow: -158848000 USD 2024-01-01 – 2024-12-31: -152996000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 5852000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IGM Biosciences, Inc. · 2024-12-31 IGM Biosciences, Inc. (edgar:1496323) Free cash flow: -158848000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:43:06Z Snapshot: a7fba78e958331d72349fee2589a0e676facfb1793379abb598a922c32a3834e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1496323?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -152996000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1958917 Filing: 000095017025034597 Input fundies:CapitalExpenditure: 5852000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1496323/000095017025034597/igms-20241231.htm#1971128 Filing: 000095017025034597 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

31 filings · 1,462 latest values · 1,462 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001496323, 1496323, IGMS, edgar:1496323

Also known as IGM Biosciences, Inc., Palingen, Inc.

IGM Biosciences, Inc.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation